Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008)

NCT00934466 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: MK2637
DRUG: Comparator: MK2637
DRUG: Comparator: Placebo
DRUG: Comparator: Dextromethorphan
DRUG: Comparator: Dextromethorphan

Sponsor

Merck Sharp & Dohme LLC